BLVRA and Alzheimer disease: In the hippocampal samples from patients with AD and mild cognitive impairment, BVR-A expression and its oxidative or nitrosative modifications are increased, whereas its phosphorylation at serine, threonine, and tyrosine residues is decreased [141,142].